ProfileGDS4718 / 235376_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 42% 32% 32% 40% 21% 24% 27% 32% 33% 34% 37% 33% 30% 20% 34% 20% 35% 33% 58% 31% 24% 33% 37% 31% 27% 32% 40% 42% 33% 25% 20% 40% 25% 28% 29% 26% 34% 32% 37% 23% 40% 36% 26% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1797844
GSM549102patient 115, normal, homogenized [OPG study]5.1145442
GSM549104patient 119, normal, homogenized [OPG study]4.6248432
GSM549108patient 138, normal, homogenized [OPG study]4.6930832
GSM549119patient 077, normal, homogenized [OPG study]5.0237940
GSM549133patient 032, cancer, homogenized [OPG study]4.1200821
GSM549139patient 042, cancer, homogenized [OPG study]4.2625824
GSM549099patient 107, normal, homogenized [OPG study]4.4574127
GSM549109patient 139, normal, homogenized [OPG study]4.6587432
GSM549110patient 046, normal, homogenized [OPG study]4.6657533
GSM549114patient 063, normal, homogenized [OPG study]4.6809734
GSM549122patient 082, normal, homogenized [OPG study]4.8415837
GSM549134patient 033, cancer, homogenized [OPG study]4.6524733
GSM549136patient 036, cancer, homogenized [OPG study]4.497730
GSM549140patient 044, cancer, homogenized [OPG study]4.1263420
GSM549111patient 047, normal, homogenized [OPG study]4.6722734
GSM549113patient 057, normal, homogenized [OPG study]4.1049420
GSM549132patient 031, cancer, homogenized [OPG study]4.7508935
GSM549137patient 038, cancer, homogenized [OPG study]4.6433133
GSM549142patient 047, cancer, homogenized [OPG study]6.0793958
GSM549100patient 110, normal, homogenized [OPG study]4.6062131
GSM549107patient 135, normal, homogenized [OPG study]4.247124
GSM549115patient 068, normal, homogenized [OPG study]4.616133
GSM549116patient 072, normal, homogenized [OPG study]4.8136837
GSM549120patient 078, normal, homogenized [OPG study]4.6012331
GSM549131patient 030, cancer, homogenized [OPG study]4.3582727
GSM549118patient 074, normal, homogenized [OPG study]4.6044232
GSM549129patient 027, cancer, homogenized [OPG study]4.9979840
GSM549123patient 088, normal, homogenized [OPG study]5.0798942
GSM549124patient 006, cancer, homogenized [OPG study]4.7143833
GSM549126patient 015, cancer, homogenized [OPG study]4.3125725
GSM549128patient 025, cancer, homogenized [OPG study]4.1119820
GSM549103patient 117, normal, homogenized [OPG study]5.0557940
GSM549117patient 073, normal, homogenized [OPG study]4.3320525
GSM549138patient 041, cancer, homogenized [OPG study]4.4228428
GSM549141patient 045, cancer, homogenized [OPG study]4.4210629
GSM549130patient 028, cancer, homogenized [OPG study]4.3783226
GSM549101patient 111, normal, homogenized [OPG study]4.7543734
GSM549105patient 128, normal, homogenized [OPG study]4.641432
GSM549106patient 134, normal, homogenized [OPG study]4.8021137
GSM549112patient 048, normal, homogenized [OPG study]4.2427323
GSM549125patient 011, cancer, homogenized [OPG study]5.0193840
GSM549127patient 024, cancer, homogenized [OPG study]4.7870336
GSM549135patient 035, cancer, homogenized [OPG study]4.3361226